TenNor Therapeutics

TenNor Therapeutics is a clinical-stage company focused on developing new therapies for unmet needs in infectious diseases. Their lead product, rifasutenizol, targets Helicobacter pylori infection, while another, rifaquizinone, addresses medical device infections. The company utilizes a multi-targeting drug conjugate technology platform.

Buy Funded Startups lists

Funding Round: Series E

Funding Amount: ¥300M

Date: 16-Oct-2024

Investors: AMR Action Fund, Zhongshan Venture Capital

Markets: Biotechnology, Pharmaceuticals, Infectious Diseases, Drug Discovery

HQ: Suzhou, Jiangsu, China

Founded: 2013

Website: https://www.tennorx.com/

LinkedIn: https://www.linkedin.com/company/tennor

Twitter:

Instagram: